home / stock / bttx / bttx news


BTTX News and Press, Better Therapeutics Inc. From 03/18/24

Stock Information

Company Name: Better Therapeutics Inc.
Stock Symbol: BTTX
Market: NASDAQ
Website: bettertx.com

Menu

BTTX BTTX Quote BTTX Short BTTX News BTTX Articles BTTX Message Board
Get BTTX Alerts

News, Short Squeeze, Breakout and More Instantly...

BTTX - US Companies Moving the Markets, Evening edition
Mon, Mar 18, 2024 as of 4:00 pm ET

A look at the top 10 most actives in the United States Fisker Inc. Class A (FSR) fell 15.6% to $0.1475 on volume of 286,845,446 shares Verb Technology Company Inc. (VERB) fell 18.6% to $0.36 on volume of 244,515,000 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 0.0% to $3...

BTTX - US Companies Moving the Markets, Morning edition
Mon, Mar 18, 2024 as of 10.00 am ET

A look at the top 10 most actives in the United States Verb Technology Company Inc. (VERB) rose 48.6% to $0.6572 on volume of 73,080,922 shares Fisker Inc. Class A (FSR) fell 12.8% to $0.1523 on volume of 67,016,587 shares Trinity Place Holdings Inc. (TPHS) rose 289.6% to $0.3156 on volum...

BTTX - Using Social Sentiment for Penny Stocks Investing

2024-03-16 06:13:00 ET 3 Tips for Using Social Sentiment to Identify Penny Stocks to Buy Leveraging social sentiment has become a pivotal approach in identifying promising penny stocks to buy. This strategy harnesses the collective insights and moods of investors and traders express...

BTTX - US Companies Moving the Markets, Evening edition
Fri, Mar 15, 2024 as of 4:00 pm ET

A look at the top 10 most actives in the United States Verb Technology Company Inc. (VERB) rose 211.4% to $0.4422 on volume of 532,901,553 shares Fisker Inc. Class A (FSR) rose 12.8% to $0.1747 on volume of 376,460,729 shares Better Therapeutics Inc. (BTTX) rose 27.4% to $0.0446 on volume...

BTTX - VERI, STI and VERB among mid-day movers

2024-03-15 12:52:05 ET More on Mid-day movers & stocks. Veritone, Inc. (VERI) Q4 2023 Earnings Call Transcript Solidion Technology climbs 10% on $3.85M private placement Veritone Non-GAAP EPS of -$0.16 in-line, revenue of $34.2M beats by $0.4M Financial i...

BTTX - Geron, Graphite Bio, Immuneering among healthcare movers

2024-03-15 10:00:13 ET More on Health Care Select Sector SPDR XLV: Low-Cost Exposure To A Defensive Sector, While Achieving Strong Performance Healthcare In 2024: Navigating The Biopharma Bull Run XLV Likely Back To Outperforming Johnson & Johnson, Boston...

BTTX - US Companies Moving the Markets, Morning edition
Fri, Mar 15, 2024 as of 10.00 am ET

A look at the top 10 most actives in the United States Grab Holdings Limited (GRAB) fell 0.2% to $3.235 on volume of 103,635,000 shares Better Therapeutics Inc. (BTTX) rose 108.6% to $0.073 on volume of 98,804,254 shares Verb Technology Company Inc. (VERB) rose 156.3% to $0.3639 on volume...

BTTX - US Companies Moving the Markets, Evening edition
Thu, Mar 14, 2024 as of 4:00 pm ET

A look at the top 10 most actives in the United States Fisker Inc. Class A (FSR) fell 51.9% to $0.1549 on volume of 312,863,578 shares Direxion Daily Semiconductor Bear 3X Shares (SOXS) rose 5.4% to $3.51 on volume of 229,852,079 shares SoundHound AI Inc. (SOUN) fell 3.2% to $8.37 on volu...

BTTX - Better Therapeutics Announces it will Seek Strategic Alternatives and will be Delisted from Nasdaq

Better Therapeutics, Inc. (NASDAQ: BTTX) (the “Company”) announced today that the Company is terminating its employees and will explore strategic alternatives, including assignment for the benefit of creditors and/or a wind-down of the Company. This decision was made at a special ...

BTTX - Better Therapeutics Announces an Innovative Partnership with the American College of Lifestyle Medicine to Expand Access to AspyreRx Across 1,400 Federally Qualified Health Centers

One million prescriptions for AspyreRx will be offered to patients in underserved communities disproportionately affected by type 2 diabetes Better Therapeutics, Inc. (NASDAQ: BTTX), a pioneer in developing prescription digital therapeutics (PDTs) for treating cardiometabolic diseas...

Previous 10 Next 10